Core SmPC and package leaflet for sodium iodide (131 I) for therapeutic use - Scientific guideline

HumanScientific guidelines

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

This guideline describes the information to be included in the Summary of Product Characteristics (SmPC) and package leaflet for sodium iodide (131I) for therapeutic use.

Keywords: Radiopharmaceuticals, radionuclide, kit for radiopharmaceutical preparation, core SmPC, core package leaflet, sodium iodide (131I), therapeutic use

Current effective version

Guideline on core SmPC and package leaflet for sodium iodide (131I) for therapeutic use

Adopted Reference Number: EMA/CHMP/630248/2017

English (EN) (302.89 KB - PDF)

Pirmą kartą paskelbta: Paskutinį kartą atnaujinta:
Rodyti

Document history

Submission of comments on 'Guideline on core SmPC and Package Leaflet for sodium iodide (131I) therapy capsule' (EMA/CHMP/649301/2016)

Reference Number: EMA/630247/2017

English (EN) (438.63 KB - PDF)

Pirmą kartą paskelbta: Paskutinį kartą atnaujinta:
Rodyti

Draft guideline on core SmPC and Package Leaflet for sodium iodide (131I) therapy capsule

Draft: consultation closed Consultation dates: to Reference Number: EMA/CHMP/649301/2016 Summary:

This guideline describes the information to be included in the Summary of Products Characteristics (SmPC) and package leaflet for sodium iodide (131I) therapy capsule.

English (EN) (300.66 KB - PDF)

Pirmą kartą paskelbta: Paskutinį kartą atnaujinta:
Rodyti

Share this page